Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fluzone Intradermal Quadrivalent
- Development stage
- Approved
- Lead developer
- Sanofi
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intradermal
01
Overview
Fluzone Intradermal Quadrivalent is an inactivated, quadrivalent influenza vaccine developed by Sanofi Pasteur for the prevention of influenza disease caused by influenza A subtype viruses and type B viruses. It contains hemagglutinin (HA) from four killed influenza virus strains: two influenza A (H1N1 and H3N2) and two influenza B (one from each lineage, Victoria and Yamagata). Unlike standard intramuscular vaccines, it is administered intradermally using a specialized microinjection system with a 1.5 mm needle, delivering the vaccine into the dermal layer of the skin where immune cells are highly concentrated. It was FDA-approved in 2014 for use in adults aged 18 through 64 years.
- Brand names
- Fluzone Intradermal Quadrivalent
- Other names
- Fluzone ID QuadrivalentFluzone Quadrivalent Intradermal
02
Targets
HA (Hemagglutinin)
Beyond the preview
Go deeper on Fluzone Intradermal Quadrivalent.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Fluzone Intradermal Quadrivalent.